Skip to Main Content



Breakthroughs for epilepsy and prevention

Pharmacology researchers make breakthrough discoveries in using CBD to treat and prevent hard-to-treat forms of epilepsy.

Nano-size carbon material could be used to treat Down syndrome

Innovation can manage toxic levels of hydrogen sulfide that occur in this and many other disorders

How does Lyme disease wreak havoc on humans? Interdisciplinary team of Texas A&M scientists looks for answers

Researchers publish findings in the Journal of Immunology
Biomedical Sciences

BET inhibitors could break link between colorectal cancer and COVID-19, new Texas A&M study says

Researchers publish findings in the journal Precision Oncology

NIH awards five-year grant for multidisciplinary A&M team to bring 3D printing of pediatric drugs to hospitals

Researchers include faculty from pharmacy, engineering, arts and sciences, and veterinary medicine and biomedical sciences

Deep-learning model predicts mRNA degradation to improve stability in thermally sensitive vaccines

A&M engineers publish findings in the journal Briefings in Bioinformatics

Diet may contribute to development of Alzheimer’s disease, according to new NIH-funded study

Texas A&M researchers publish findings in FEBS Journal

Detecting preeclampsia during first trimester: Lab at Texas A&M secures biomarker patent

Complication doubles for expectant mothers with COVID-19, data indicates
Cell Biology and Genetics

New treatment for brain trauma: Single-dose nasal spray could halt cycle of neuroinflammation

A&M researchers publish findings in the journal Brain Behavior and Immunity